Abstract:ABSTRACT The gut microbiota is inextricably linked to human health and disease. It can confer colonization resistance against invading pathogens either through niche occupation and nutrient competition or via its secreted metabolites. Short-chain fatty acids (SCFA) are the primary metabolites in the gut as a result of dietary fiber fermentation by the gut microbiota. In this work, we demonstrate that the interaction of single-species gut commensals on solid media is insufficient for pathogen inhibition, but supernatants from monocultures of these commensal bacteria enriched in acetate confer inhibition against anaerobic growth of the enteric pathogen Klebsiella pneumoniae . The three primary SCFAs (acetate, propionate, and butyrate) strongly inhibit the intestinal commensal Escherichia coli Nissle as well as a panel of enteric pathogens besides K. pneumoniae at physiological pH of the cecum and ascending colon. This inhibition was significantly milder on anaerobic gut commensals Bacteroides thetaiotaomicron and Bifidobacterium adolescentis previously demonstrated to be associated with microbiota recovery after antibiotic-induced dysbiosis. We describe a general suppression of bacterial membrane potential by these SCFAs at physiological cecum and ascending colonic pH. Furthermore, the strength of bacterial inhibition increases with increasing alkyl chain length. Overall, the insights gained in this study shed light on the potential therapeutic use of SCFAs for conferring colonization resistance against invading pathogens in a dysbiotic gut. IMPORTANCE Rising antimicrobial resistance has made treatment of bacterial infections increasingly difficult. According to the World Health Organization, it has become a burgeoning threat to hospital and public health systems worldwide. This threat is largely attributed to the global rise of carbapenem-resistant Enterobacteriaceae in recent years, with common hospital-acquired pathogens growing increasingly resistant to last-line antibiotics. Antibiotics disrupt the homeostatic balance of the gut microbiota, resulting in the loss of colonization resistance against enteric pathogens. This work describes the ability of short-chain fatty acids (SCFAs) produced by gut microbiota to be effective against a wide panel of enteric pathogens without major impact on common gut commensal species. We also demonstrate a previously undescribed link between alkyl chain length and antibacterial effects of SCFAs. SCFAs, thus, hold promise as an alternative therapeutic option leveraging on the antimicrobial activity of these endogenously produced gut metabolites without disrupting gut microbiota homeostasis.

Bacterial short‐chain fatty acid metabolites modulate the inflammatory response against infectious bacteria

Short‐chain Fatty Acids Regulate B Cells Differentiation Via the FFA2 Receptor to Alleviate Rheumatoid Arthritis

Regulation of inflammation by short chain fatty acids

Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils

Regulation of immune cell function by short-chain fatty acids

The Short-Chain Fatty Acids Propionate and Butyrate Augment Adherent-Invasive Escherichia Coli Virulence but Repress Inflammation in a Human Intestinal Enteroid Model of Infection

Short chain fatty acids regulation of neutrophil production of IL-10

Short-chain Fatty Acids Produced by Anaerobic Bacteria Alter the Physiological Responses of Human Neutrophils to Chemotactic Peptide.

Regulation of short-chain fatty acids in the immune system

Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections

Short-chain fatty acids as a potential treatment for infections: a closer look at the lungs

Commensal-derived short-chain fatty acids disrupt lipid membrane homeostasis in Staphylococcus aureus

Microbiota-derived Short Chain Fatty Acids: Their Role and Mechanisms in Viral Infections

Short-chain fatty acids inhibit the activation of T lymphocytes and myeloid cells and induce innate immune tolerance

Short-chain Fatty Acids Act As Antiinflammatory Mediators by Regulating Prostaglandin E(2) and Cytokines.

Short-Chain Fatty Acid and FFAR2 Activation - A New Option for Treating Infections?

The Three Main SCFAs Inhibit the Inflammatory Response of A549 Cells Induced by Acinetobacter Baumannii

Short-chain fatty acids: linking diet, the microbiome and immunity

Divergent effect of the anaerobic bacteria by-product butyric acid on the immune response: suppression of T-lymphocyte proliferation and stimulation of interleukin-1 beta production.

Short-chain fatty acids of various lengths differentially inhibit Klebsiella pneumoniae and Enterobacteriaceae species

Short-Chain Fatty Acids Modulate Metabolic Pathways and Membrane Lipids in Prevotella bryantii B14